News
A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
The cause of death has been confirmed for Michelle Trachtenberg, the 39-year-old actress who was found dead in a New York ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results